期刊文献+

对早期凋亡细胞的吞噬抑制T淋巴细胞活化的实验研究 被引量:1

Phagocytosis of viable apoptotic cells inhibits the activation of T lymphocytes
暂未订购
导出
摘要 目的研究早期凋亡细胞及吞噬早期凋亡细胞的巨噬细胞对T淋巴细胞活化的影响。方法体外以紫外线照射,诱导出早期凋亡的Jurkat细胞;建立早期凋亡细胞的吞噬模型;ELISA法分析早期凋亡细胞对LPS刺激下巨噬细胞分泌细胞因子的影响及在早期凋亡细胞和吞噬了早期凋亡细胞的巨噬细胞干预下,ConA刺激T淋巴细胞活化后CD69、CD25、CD71表达的变化。结果巨噬细胞吞噬了早期凋亡细胞后,抑制性细胞因子(TGFβ1)的分泌明显上调,并且在一定程度上抑制了ConA刺激下的T淋巴细胞活化;具体表现为CD69、CD25、CD71等T淋巴细胞活化标志的表达受到明显抑制。当加入TGFβ1中和抗体后,这种抑制作用消失。结论巨噬细胞吞噬了早期凋亡细胞后抑制ConA刺激下的T淋巴细胞CD69、CD25、CD71的表达,这种抑制作用依赖于的TGFβ1分泌增强。 AIM: To investigate whether viable apoptotic cells and phagocytosis of them affect the activation of T lymphocytes. METHODS: Ultraviolet irradiation was used to induce apoptotic cells in vitro and the model of phagocytosis of these cells was established. Cytokine TGF β1 was detected by ELISA. The rate of apoptotic cells and phagocytosis of them were assessed by flow cytometry. Furthermore, flow cytometry was also employed to examine the expression of activation signs, such as CD69, CD25, CD71, of T lymphocytes under the intervention of apoptotic cells and macrophage which ingested apoptotic cells, to reflect whether the apoptotic cells and the phagocytosis of these cells could influence the activation of lymphocytes stimulated by Con A. RESULTS: Ingestion of apoptotic cells increased TGF β1 secretion. Only the macrophages that had ingested apoptotic cells could suppress the activation of lymphocytes. The expression of the markers of lymphocytes activation such as CD69, CD25, CD71 had been restrained. These inhibition effects were abolished by monoclonal anti-TGF β1 antibody. CONCLUSION: The macrophages that have ingested apoptotic cells inhibit expression of CD69, CD25 and CD71 of T lymphocytes stimulated by ConA. This effect is dependent on the increase in TGF β1 secretion in local site. [
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2004年第12期2180-2184,共5页 Chinese Journal of Pathophysiology
基金 国家重点基础研究发展计划(973计划)项目(No.2003CB515500)
关键词 凋亡细胞 T淋巴细胞 Apoptosis T-lymphocytes
  • 相关文献

参考文献9

  • 1Lynch DH, Ramsdell F, Alderson MR, et al. Fas and FasL in the homeostatic regulation of immune responses[J]. Immunol Today, 1995, 16(12): 569-574.
  • 2Reinhard EV, Martin H, Editha R, et al. Immunosuppressive effect of apoptotic cells[J]. Nature, 1997, 390(27): 350-351.
  • 3Valerie AF, Donna L, Konowal A, et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β1, PGE2, and PAF[J]. J Clin Invest, 1998, 101(4): 890-898.
  • 4Savill J, Dransfield I, Gregory C, et al. A blast from the past:Clearance of apoptotic cells regulates immune responses[J]. Nature Rev Immunol, 2002, 2(12): 965-975.
  • 5Ronchetti A, Rovere P, Lezzi G, et al. Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokins[J]. J Immunol, 1999, 163(1): 130-136.
  • 6Crabtree GR. Contingent genetic regulatory events in T lymphocyte activation[J]. Science, 1989, 243(4889):355-361.
  • 7Mai-lan N Huynh, Valerie A Fadok, Peter M Henson, et al. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation[J]. J Clin Invest, 2002, 109(1): 41-50.
  • 8Sun EW, Shi YF. Apoptosis: the quiet death silence the immune system[J]. Pharmacol Ther, 2001, 92(2): 135-145.
  • 9Levine JS, Koh JS, SubAng R, et al. Apoptotic cells as immunogen and antigen in the antiphospholipid syndrome[J]. Exp Mol Pathol, 1999, 66(1): 82-98.

同被引文献13

  • 1Jiang H,Granville DJ,North JR,et al.Selective action of the photosensitizer QLT0074 on activated human T lymphocytes[J].Photochem Photobiol,2002,76(2):224 - 231.
  • 2Bissonnette R,Tremblay JF,Juzenas P,et al.Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques [J].J Invest Dermatol,2002,119(1):77-83.
  • 3Janssen EM,Droin NM,Lemmens EE,et al.CD4 + T- cell help controls CD8 + T - cell memory via TRAIL - mediated activation- induced cell death [J].Nature,2005,434(7029):88 - 93.
  • 4Hugues S,Fetler L,Bonifaz L,et al.Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity[J].Nat Immunol,2004,5(12):1235-1242.
  • 5Siminovitch KA.PTPN22 and autoimmune disease[J].Nat Genet,2004,36(12):1248-1249.
  • 6Van Kaer L.Alpha- galactosylceramide therapy for autoimmune diseases:prospects and obstacles [J].Nat Rev Immunol,2005,5(1):31-42.
  • 7O'shea JJ,Pesu M,Borie DC,et al.A new modality for immunosuppression:targeting the JAK/STAT pathway[J].Nat Rev Drug Discov,2004,3(7):555- 564.
  • 8Hackstein H,Thomson AW,et al.Dendritic cells:emerging pharmacological targets of immunosuppressive drugs [J].Nat Rev Immunol,2004,4(1):24-34.
  • 9Hryhorenko EA,Rittenhouse- Diakun K,Harvey NS,et al.Characterization of endogenous protoporphyrin Ⅸ induced by delta- aminolevulinic acid in resting and activated peripheral blood lymphocytes by four - color flow cytometry [J].Photochem Photobiol,1998,67(5):565-572.
  • 10Hunt DW,Jiang H,Granville DJ,et al.Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes[J].Immunopharmacology,1999,41(1):31-44.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部